Institutions
Anselme Perrier
Neurodegenerative Diseases
Inserm/UEVE UMR 861, I-Stem, AFM
Genopole Campus 1,
5 rue Henri Desbruères,
91030 EVRY Cedex
Tel +33 1 6990 8523
Drug discovery for genetic diseases: Screening technologies are applied to identify chemical compounds able to inhibit REST function, a major target gene in Huntington’s disease, and will serve as a paradigm for high-throughput screening approaches applied to neurological disorders.